CMS Open Payments · Program Year 2024
Spinal Simplicity, LLC
Spinal Simplicity, LLC reported $40,806,707.35 across General Payments, Research, and Ownership to 4,988 physicians and teaching hospitals across 5,105 transactions.
- $40.8M
- All-tracks total
- 5,105
- Transactions
- 4,988
- Recipients
- −$83.4K
- General Payments vs PY2023
Spinal Simplicity, LLC reported $40,806,707.35 across all CMS Open Payments tracks (General + Research + Ownership) to 4,988 physicians and teaching hospitals in Program Year 2024 - ranking #57 of 1,925 reporting manufacturers (0.3% of the all-tracks industry total); General Payments alone were $752,579.53, averaging $8.2K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer spinal-simplicity-llc Spinal Simplicity, LLC
$40.8M · #57/1,925 · 0.3% industry · PY2024
- TOT $40.8M
- RANK #57
- SHARE 0.3%
- TXN 5,105
- RCP 4,988
- CAT 4
- GEN $752.6K
- ΔGEN −$83.4K
- TOP1 8.8%
- PY 2024
Volume peers
Nearest volume peer: Boehringer Ingelheim International GmbH ($41.1M)
Spinal Simplicity, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Spinal Simplicity, LLC's CMS-reported General Payments decreased by $83.4K (−10.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SPINAL SIMPLICITY, LLCPY2023: SPINAL SIMPLICITY, LLCPY2024: Spinal Simplicity, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $835,981.10
- PY2024
- $752,579.53
What the Data Shows for Spinal Simplicity, LLC
Averaging $8.0K per transaction and $8.2K per recipient, Spinal Simplicity, LLC's Program Year 2024 total comes to $40,806,707.35 across 5,105 transactions and 4,988 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #57 of 1,925 companies, representing 0.3% of all industry payments reported nationwide for the year.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $215.1K, accounting for 28.6% of this company's General Payments and 958 transactions.
General Payment Breakdown by Type
"Travel and Lodging" leads Spinal Simplicity, LLC's 4-category general-payment breakdown at $215.1K, 28.6% of the reported total.
Spinal Simplicity, LLC reports 4 general-payment categories - the top three are Travel and Lodging (28.6%), Education (27.2%), and Food and Beverage (22.4%). The remaining 1 category make up 21.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Spinal Simplicity, LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $215.1K | 958 | 28.6% |
| Education | $204.6K | 67 | 27.2% |
| Food and Beverage | $168.8K | 3,889 | 22.4% |
| Consulting Fee | $164.1K | 74 | 21.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $209,089.12 (27.8%) of $752,579.53 in this company's General Payments records across 1,356 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Spinal Simplicity, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Chad Stephens
$66,228.38 across 113 reported transactions
- 2
Baher Yanni
$49,002.11 across 51 reported transactions
- 3
Ryan Budwany
$35,486.91 across 73 reported transactions
- 4
Kaku Barkoh
$29,376.24 across 60 reported transactions
- 5
Timothy Deer
$28,995.48 across 20 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Spinal Simplicity, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Spinal Simplicity, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Spinal Simplicity, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Alnylam Pharmaceuticals Inc.
Sanofi Pasteur Inc.
ViiV Healthcare Company
Exelixis Inc.
Daiichi Sankyo Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.